195 related articles for article (PubMed ID: 35589331)
21. Lymphocyte subpopulations in Sjögren's syndrome are distinct in anti-SSA-positive patients and related to disease activity.
Barcelos F; Martins C; Madeira N; Ângelo-Dias M; Cardigos J; Alves N; Vaz-Patto J; Cunha-Branco J; Borrego LM
Clin Rheumatol; 2021 Jul; 40(7):2791-2804. PubMed ID: 33443605
[TBL] [Abstract][Full Text] [Related]
22. [Practicable diagnostics of Sjögren's syndrome in interstitial lung disease-A discussion article].
Aringer M; Koschel D; Dörner T; Sewerin P; Prasse A; Witte T
Z Rheumatol; 2023 May; 82(4):321-324. PubMed ID: 36949162
[TBL] [Abstract][Full Text] [Related]
23. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
24. Beyond dry eye: The greater extent of Sjögren's systemic disease symptoms, the impact of COVID-19 and perceptions towards telemedicine identified through a patient co-designed study.
Greenan E; Tynan G; Collins D; Murphy CC; Flood M; Ní Gabhann-Dromgoole J
Health Expect; 2023 Dec; 26(6):2252-2263. PubMed ID: 37470291
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing the EULAR Sjögren's Syndrome Patient-Reported Index in primary Sjögren's syndrome.
Sandoval-Flores MG; Chan-Campos I; Hernández-Molina G
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):153-158. PubMed ID: 34128801
[TBL] [Abstract][Full Text] [Related]
26. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
27. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
Bak E; Yang HK; Hwang JM
Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
[TBL] [Abstract][Full Text] [Related]
28. Corneal sub-basal nerve plexus assessment and its association with phenotypic features and lymphocyte subsets in Sjögren's Syndrome.
Barcelos F; Hipólito-Fernandes D; Martins C; Ângelo-Dias M; Cardigos J; Monteiro R; Alves N; Vaz-Patto J; da Cunha-Branco J; Borrego LM
Acta Ophthalmol; 2021 Dec; 99(8):e1315-e1325. PubMed ID: 33683020
[TBL] [Abstract][Full Text] [Related]
29. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI) and Other Patient-Reported Outcomes in the Assessment of Glandular Dysfunction in Primary Sjögren's Syndrome.
Ture HY; Kim NR; Nam EJ
Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895373
[TBL] [Abstract][Full Text] [Related]
30. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
Brito-Zerón P; Ramos-Casals M;
Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
[TBL] [Abstract][Full Text] [Related]
31. Clinical and laboratory findings of primary Sjögren's syndrome patients without sicca symptoms.
Chatzis LG; Koulouri V; Baldini C; Pezoulas VC; Voulgari PV; Skopouli FN; Fotiadis DI; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2022 Dec; 40(12):2298-2302. PubMed ID: 36200933
[TBL] [Abstract][Full Text] [Related]
32. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
Cooper C; Wratten S; Williams-Hall R; Bookman AAM; Ndife B; Hueber W; Goswami P
Rheumatol Ther; 2022 Dec; 9(6):1499-1515. PubMed ID: 36114443
[TBL] [Abstract][Full Text] [Related]
33. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
[TBL] [Abstract][Full Text] [Related]
34. Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
Oni C; Mitchell S; James K; Ng WF; Griffiths B; Hindmarsh V; Price E; Pease CT; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Hunter J; Gupta M; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman SJ;
Rheumatology (Oxford); 2016 Mar; 55(3):544-52. PubMed ID: 26510429
[TBL] [Abstract][Full Text] [Related]
35. Outcome measures for primary Sjögren's syndrome.
Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Ramos-Casals M; Ravaud P; Theander E; Tzioufas A; Vitali C
J Autoimmun; 2012 Aug; 39(1-2):97-102. PubMed ID: 22365784
[TBL] [Abstract][Full Text] [Related]
36. Concomitant fibromyalgia in primary Sjögren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
Dubost JJ; Couderc M; Pereira B; Mariette X; Seror R; Gottenberg JE; Hachulla E; Le Guern V; Saraux A; Morel J; Salliot C; Tournadre A; Soubrier M
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):140-145. PubMed ID: 34919043
[TBL] [Abstract][Full Text] [Related]
37. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
[TBL] [Abstract][Full Text] [Related]
38. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
Champey J; Corruble E; Gottenberg JE; Buhl C; Meyer T; Caudmont C; Bergé E; Pellet J; Hardy P; Mariette X
Arthritis Rheum; 2006 Jun; 55(3):451-7. PubMed ID: 16739213
[TBL] [Abstract][Full Text] [Related]
39. Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome.
Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; De Craemer AS; Van den Bosch F; Elewaut D; Peene I
Semin Arthritis Rheum; 2022 Oct; 56():152075. PubMed ID: 35907342
[TBL] [Abstract][Full Text] [Related]
40. Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry.
Shiboski CH; Baer AN; Shiboski SC; Lam M; Challacombe S; Lanfranchi HE; Schiødt M; Shirlaw P; Srinivasan M; Umehara H; Vivino FB; Akpek E; Bunya V; Vollenweider CF; Greenspan JS; Daniels TE; Criswell LA;
Arthritis Care Res (Hoboken); 2018 Feb; 70(2):284-294. PubMed ID: 28437595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
